Monday, November 30, 2020

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug The tentatively approved product is the generic version of Inlyta tablets of PF Prism CV.

from Moneycontrol Business News https://ift.tt/33u15rC

No comments:

Post a Comment

Short-term volatility may persist, but FII flows and economic activity to keep sentiment positive: Vikas Khemani

Vikas Khemani of Carnelian Asset Management remains optimistic about Indian markets, citing a strong domestic growth story and the resolutio...